查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1928549

植物来源生元纤维市场按产品类型、原料来源、形态、应用、最终用户和分销管道划分，全球预测（2026-2032年）

Plant-Derived Prebiotic Fiber Market by Product Type, Source, Form, Application, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 183 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计到 2025 年，植物来源益生元纺织品市场价值将达到 6.8321 亿美元，到 2026 年将成长至 7.3348 亿美元，到 2032 年将达到 10.1812 亿美元，复合年增长率为 5.86%。

关键市场统计数据
基准年 2025 6.8321亿美元
预计年份：2026年 7.3348亿美元
预测年份 2032 10.1812亿美元
复合年增长率 (%) 5.86%

本书以清晰易懂的科学视角，介绍了植物来源益生元纤维，重点阐述了正在重塑配方选择的科学原理、供应和商业性因素。

植物来源生元纤维融合了营养科学、永续采购和成分创新，正在重塑食品、饮料、膳食补充剂、动物饲料和药物製剂等领域的产品开发。分析方法和萃取技术的进步，使生产者能够生产出具有特定分子特征的高效功能性纤维，从而支持肠道健康、血糖值调节和消化器官系统健康。这些特性满足了消费者对洁净标示、科学功效和可追溯性的需求，同时，明确健康声明和标籤要求的法规结构也在不断发展和改进。

萃取创新、经证实的功效和永续性采购如何从根本上重新定义该产业的竞争优势

近年来，植物来源生元纤维领域经历了变革性的转变，其意义远不止于产品本身的逐步改进，而是涵盖了供应链结构、配方技术和商业化等方面的根本性变革。萃取和纯化技术的进步使得高纯度组成和新型基质的製备成为可能，从而能够精准靶向微生物群落和宿主反应。同时，消费者对洁净标示、低加工成分的需求日益增长，促使供应商更加重视原料来源的检验，并减少合成加工助剂的使用。这种功能特性更加清晰、来源更可靠的趋势，正推动价值提案从商品定价转向基于性能和品牌故事的差异化。

对受2025年后关税变化影响的整个产业的策略采购、配方调整和供应链韧性措施进行详细分析

美国关税于2025年生效，其累积影响波及植物来源生元纤维的筹资策略、定价及供应商关係。依赖进口的製造商被迫重新评估其供应商组合，并寻求在地采购方案，以降低成本波动和贸易摩擦的风险。因此，采购部门加快了国内及週边供应商的资质认证，一些配方师也调整了产品规格，以采用功能特性相近的植物性替代成分。在无法进行替代的情况下，企业要么暂时承担更高的原材料成本，要么透过谈判签订长期合约来稳定价格并确保供应的持续性。

多面向細項分析揭示了产品类型、原材料来源、应用领域、最终用户、分销管道和产品形式如何驱动差异化的价值提案。

细分市场分析揭示了产品类型、应用、原材料来源、最终用户、分销管道和剂型等不同的价值驱动因素，这些因素共同塑造了商业策略。依产品类型划分，我们检视了寡果醣、半乳寡糖、菊糖、果胶和抗性糊精。每类产品都有不同的溶解性、甜度和发酵特性，这些特性会影响配方和剂量。按应用划分，我们分析了饲料、营养保健品、食品饮料和製药市场。每种应用都有其独特的法规要求、稳定性要求和效能限制，这些因素会影响供应商的选择和规格要求。按成分划分，我们分析了香蕉、菊苣根、大蒜、菊芋和洋葱的市场，重点关注植物来源成分对感官属性、辅助营养素基质和永续性叙事的影响，这些在品牌故事中日益重要。

区域观点着重分析美洲、欧洲、中东和非洲以及亚太地区的独特需求模式、法规环境和关键采购挑战。

区域趋势正在重塑供需格局，这要求企业采取差异化的市场进入、采购和商业化策略。在美洲，消费者对肠道健康的日益关注、成熟的膳食补充剂体係以及对生产能力的持续投资，共同支撑了对经临床检验的成分和高端配方的需求。同时，北美和拉丁美洲的供应链各自拥有独特的采购机会和物流考量，必须兼顾监管标籤标准和贸易政策趋势。

企业策略和竞争动态凸显了创新、垂直整合和科学信誉如何创造持久的差异化优势。

公司层面的发展趋势取决于产品创新、供应链整合和市场进入柔软性的综合考量。领先的原料生产商正投资于先进的分馏技术、临床试验项目以及学术合作伙伴关係，以增强产品功效并打造差异化的产品规格。同时，一些公司正寻求垂直整合，将上游工程的种植、提取和纯化能力纳入公司内部，以控制利润率并提高可追溯性；而另一些公司则选择策略联盟和契约製造协议，以保持灵活性并降低资本支出。

为平衡供应多元化、临床投资、永续性和通路特定产品设计，提供切实可行的策略建议

产业领导者应采取以组合为导向的方法，同时应对供应风险、证据产生和市场管道优化。首先，应实现植物原料来源和合格管道的多元化，以减少对单一来源的依赖，并在不影响功能性能的前提下实现快速替代。这应与供应商发展计划和多年期合约相结合，以推动品质改进和产能投资。其次，应优先进行针对高价值应用（例如婴幼儿营养品和药品补充剂）的临床和作用机制研究，以确保其功效声明的可靠性和高端定位。合作试验和真实世界证据研究可以加速产品接受度，并减少商业化阻力。

为了支持这些建议，我们采用了一种透明且可重复的调查方法：结合了初步访谈、文献综合、细分映射和专家检验。

本分析采用的调查方法结合了定性和定量技术，以确保获得可靠且可操作的见解。主要研究包括对行业高管、配方科学家、采购人员和通路合作伙伴进行结构化访谈，以收集有关采购限制、应用需求和商业化策略的第一手资讯。次要研究包括仔细审查同行评审期刊、监管建议、专利趋势和公开信息，检验技术声明并确定创新路径。数据三角验证确保研究结果既反映了市场实践，也反映了益生元功能的最新科学认知。

一份简明扼要、全面全面的分析报告，重点阐述了科学证据、供应链韧性和商业性导向相结合对于确保长期竞争优势的重要性。

总之，植物来源生元纤维正处于策略转折点，科学严谨性、供应链韧性和商业性创新将决定市场走向。该产业正从以大宗商品主导的动态转型为基于临床证据、来源透明度和特定应用效能的差异化提案。随着贸易措施和区域动态的变化，那些积极拓展供应来源、优先考虑高价值临床证据并优化产品形式以适应通路需求的企业，将保持战略选择权并抓住高端市场机会。

目录

第一章：序言

第二章调查方法

  • 研究设计
  • 研究框架
  • 市场规模预测
  • 数据三角测量
  • 调查结果
  • 调查前提
  • 调查限制

第三章执行摘要

  • 首席体验长观点
  • 市场规模和成长趋势
  • 2025年市占率分析
  • FPNV定位矩阵，2025
  • 新的商机
  • 下一代经营模式
  • 产业蓝图

第四章 市场概览

  • 产业生态系与价值链分析
  • 波特五力分析
  • PESTEL 分析
  • 市场展望
  • 上市策略

第五章 市场洞察

  • 消费者洞察与终端用户观点
  • 消费者体验基准
  • 机会地图
  • 分销通路分析
  • 价格趋势分析
  • 监理合规和标准框架
  • ESG与永续性分析
  • 中断和风险情景
  • 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章植物来源益生元纤维市场（依产品类型划分）

  • 寡果醣
  • 半乳寡糖
  • 菊糖
  • 果胶
  • 抗性糊精

第九章植物来源益生元纤维市场（依来源划分）

  • 香蕉
  • 菊苣根
  • 蒜
  • 菊芋
  • 洋葱

第十章植物来源生元纤维市场（按类型划分）

  • 胶囊
  • 液体
  • 粉末

第十一章植物来源益生元纤维市场（依应用领域划分）

  • 动物饲料
  • 营养补充品
  • 食品/饮料
  • 製药

第十二章植物来源益生元纤维市场（以最终用户划分）

  • 畜牧业
  • 机能性食品
  • 婴儿奶粉
  • 运动营养

第十三章植物来源益生元纤维市场（依通路划分）

  • 离线
    • 便利商店
    • 专卖店
    • 超级市场和大卖场
  • 在线的
    • 厂商直销网站
    • 电子商务平台

第十四章 各地区植物来源生元纤维市场

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 欧洲、中东和非洲
    • 欧洲
    • 中东
    • 非洲
  • 亚太地区

第十五章植物来源益生元纤维市场：依类别划分

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第十六章 各国植物来源生元纤维市场

  • 我们
  • 加拿大
  • 墨西哥
  • 巴西
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 义大利
  • 西班牙
  • 中国
  • 印度
  • 日本
  • 澳洲
  • 韩国

17. 美国植物来源生元纤维市场

第十八章：中国植物来源生元纤维市场

第十九章 竞争情势

  • 市场集中度分析，2025年
    • 浓度比（CR）
    • 赫芬达尔-赫希曼指数 (HHI)
  • 近期趋势及影响分析，2025 年
  • 2025年产品系列分析
  • 基准分析，2025 年
  • Baolingbao Biology Co., Ltd.
  • Beneo GmbH
  • Biofeed Technology, Inc.
  • Cargill, Incorporated
  • Cosucra Groupe Warcoing SA
  • DuPont de Nemours, Inc.
  • FrieslandCampina Ingredients BV
  • FUBON Precison Co., Ltd.
  • Guangdong VTR Bio-Tech Co., Ltd.
  • Ingredion Incorporated
  • Kerry Group plc
  • Lallemand Inc.
  • Matrix Nutrition Inc.
  • New Francisco Biotechnology Corporation
  • Nissin Sugar Manufacturing Co., Ltd.
  • Orffa Additives BV
  • Quantum Hi-Tech（Beijing）Biotechnology Co., Ltd.
  • Sensient Technologies Corporation
Product Code: MRR-92740D85F027

The Plant-Derived Prebiotic Fiber Market was valued at USD 683.21 million in 2025 and is projected to grow to USD 733.48 million in 2026, with a CAGR of 5.86%, reaching USD 1,018.12 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 683.21 million
Estimated Year [2026] USD 733.48 million
Forecast Year [2032] USD 1,018.12 million
CAGR (%) 5.86%

A clear, evidence-driven introduction to plant-derived prebiotic fiber highlighting science, supply, and commercial forces reshaping formulation choices

Plant-derived prebiotic fiber represents an intersection of nutrition science, sustainable sourcing, and ingredient innovation that is reshaping product development across food, beverage, dietary supplements, animal feed, and pharmaceutical formulations. Drawing on advances in analytical methods and extraction technology, manufacturers are increasingly able to produce stable, functional fibers with targeted molecular profiles that support gut health, glycemic modulation, and digestive wellness. These attributes are resonating with consumers who prioritize clean labels, evidence-backed benefits, and traceability, while regulatory frameworks continue to evolve to clarify health claims and labeling requirements.

Against this backdrop, the industry is driven by two converging forces: demand for clinically relevant, well-characterized fibers and the need to decouple supply chains from volatile commodity cycles. Consequently, R&D investments are focusing on enhancing functionality, improving sensory profiles, and optimizing dosage formats for diverse applications, while procurement teams are exploring alternative botanical sources and strategic partnerships to secure consistent supply. Moreover, cross-disciplinary collaborations among ingredient manufacturers, academic researchers, and product formulators are accelerating translational science-turning mechanistic insights about microbiome modulation into pragmatic ingredient specifications.

Taken together, these dynamics create both opportunities and responsibilities for stakeholders. Manufacturers must demonstrate robust evidence of functional benefit and ensure scalability of sourcing, whereas brand owners need to balance efficacy claims with clear communication. As the ecosystem evolves, companies that combine rigorous science, transparent sourcing, and application-ready formats will be best positioned to convert scientific credibility into market traction.

How extraction innovations, claim substantiation, and sustainability-driven sourcing are fundamentally redefining competitive advantages in the sector

Recent years have witnessed transformative shifts in the plant-derived prebiotic fiber landscape that extend beyond incremental product improvements to structural changes in supply, formulation, and commercialization. Technological advances in extraction and refinement are enabling higher-purity fractions and novel matrices, which in turn facilitate precise targeting of microbial taxa and host responses. Simultaneously, the industry is responding to intensified consumer demand for clean-label, minimally processed ingredients, prompting suppliers to validate provenance and reduce synthetic processing aids. This combination of better-defined functional profiles and stronger provenance narratives has shifted the value proposition from commodity pricing to performance- and story-driven differentiation.

In parallel, regulatory scrutiny and claim substantiation requirements have raised the bar for evidence, encouraging the adoption of standardized clinical endpoints and biomarker-based validation. As a result, companies are investing more in clinical trials and real-world evidence generation, leading to a more rigorous commercialization pathway for high-value prebiotic ingredients. Furthermore, distribution dynamics are shifting as e-commerce and direct-to-consumer channels exert pressure on traditional retail models; brands are leveraging digital channels to educate consumers about microbiome science and dosages, enabling more targeted positioning.

Finally, strategic sourcing and sustainability goals are reshaping raw-material decisions. Suppliers are exploring underutilized botanical sources and optimizing agricultural practices to enhance yield and traceability while mitigating climate and geopolitical risks. Taken together, these shifts are not merely evolutionary but transformative, creating new competitive vectors for firms that can align scientific credibility, sustainable sourcing, and agile go-to-market execution.

A detailed appraisal of how post-2025 tariff shifts prompted strategic sourcing, reformulation, and supply chain resilience measures across the industry

The cumulative impact of the United States tariffs implemented in 2025 has produced reverberations across procurement strategies, price discovery, and supplier relationships for plant-derived prebiotic fibers. Import-dependent manufacturers were compelled to reassess supplier portfolios and explore localized sourcing as a means to moderate cost volatility and reduce exposure to trade friction. Consequently, procurement teams accelerated qualification of domestic and near-shore suppliers, while some formulators adjusted product specifications to accommodate alternative botanical inputs that offered comparable functional profiles. Where substitution was not feasible, companies absorbed higher input costs temporarily or negotiated longer-term contracts to stabilize pricing and ensure continuity of supply.

In addition, the tariff environment altered route-to-market economics, with distribution channels reassessing inventory strategies and lead times to maintain service levels. Retailers and brand owners faced trade-offs between passing costs to consumers and protecting margin, which in some cases led to reformulation, smaller pack sizes, or value-based tiering. Regulatory and trade compliance functions likewise grew in prominence, as companies sought tariff classification clarity and explored duty mitigation options such as free trade agreements, tariff engineering, and bonded warehousing. These operational adjustments were complemented by increased investment in supply chain transparency initiatives, since improved traceability can support preferential treatment under origin-specific rules.

Importantly, the tariffs catalyzed strategic responses that extended beyond immediate cost considerations. Firms with robust R&D and manufacturing capabilities accelerated vertical integration and contract manufacturing partnerships to capture more of the value chain, while others pursued joint ventures to secure access to critical botanical sources. As a result, the post-2025 landscape is characterized by greater diversification of supply, renewed emphasis on domestic capacity building, and more sophisticated risk-management frameworks that balance cost, quality, and continuity.

A multidimensional segmentation analysis revealing how product type, source, application, end user, distribution channel, and form drive differentiated value propositions

Segmentation insight reveals differentiated value drivers across product types, applications, sources, end users, distribution channels, and forms that collectively shape commercial strategy. Based on Product Type, market is studied across Fructo-Oligosaccharides, Galacto-Oligosaccharides, Inulin, Pectin, and Resistant Dextrin, and each class exhibits distinct solubility, sweetness, and fermentability profiles that influence formulation and dosing. Based on Application, market is studied across Animal Feed, Dietary Supplements, Food And Beverage, and Pharmaceuticals, with each application imposing its own regulatory, stability, and functional-performance constraints that dictate supplier selection and specification requirements. Based on Source, market is studied across Banana, Chicory Root, Garlic, Jerusalem Artichoke, and Onion, illuminating how botanical provenance affects sensory attributes, co-nutrient matrices, and sustainability narratives that are increasingly relevant to brand storytelling.

Further nuance emerges when examining end-user segmentation. Based on End User, market is studied across Animal Husbandry, Functional Food, Infant Formula, and Sports Nutrition, where divergent tolerances for ingredient cost, purity, and clinical support drive distinct purchasing behavior. Distribution dynamics are also critical: Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Convenience Stores, Specialty Stores, and Supermarket And Hypermarket, while the Online is further studied across Direct Manufacturer Websites and E-Commerce Platforms. These channels differ in merchandising requirements, shelf-life constraints, and educational needs, influencing packaging, SKU assortment, and promotional strategy. Finally, delivery format matters: Based on Form, market is studied across Capsules, Liquid, and Powder, each offering trade-offs related to dosage accuracy, consumer convenience, and formulation compatibility.

Taken together, these segmentation lenses enable stakeholders to align product design with end-market imperatives, prioritize clinical evidence for high-value applications, and tailor channel strategies to optimize reach and conversion. Strategic decisions informed by this multi-dimensional segmentation are better positioned to address functional expectations while meeting commercial constraints.

Regional perspectives that illuminate distinct demand patterns, regulatory environments, and sourcing imperatives across the Americas, EMEA, and Asia-Pacific

Regional dynamics are shaping supply and demand patterns in ways that require differentiated strategies for market entry, sourcing, and commercialization. In the Americas, a convergence of consumer interest in gut health, established nutraceutical frameworks, and ongoing investments in manufacturing capacity support demand for clinically validated ingredients and premium formulations. Meanwhile, North American and Latin American supply chains each present unique sourcing opportunities and logistical considerations that must be balanced against regulatory labeling norms and trade policy developments.

Europe, Middle East & Africa presents a heterogeneous landscape where rigorous regulatory environments and high consumer awareness of functional ingredients coexist with divergent agricultural capabilities and trade corridors. In several markets within this region, policymakers and industry stakeholders emphasize sustainability credentials and traceability, which amplifies the importance of provenance and certification schemes. Additionally, regional trade relationships and regulatory harmonization efforts influence cross-border ingredient flows and commercial partnerships.

Asia-Pacific continues to exhibit rapid innovation in application formats and distribution models, driven by a large and diverse consumer base, expanding retail channels, and strong R&D ecosystems. Local botanical sources are important in the region, and manufacturers often prioritize formulations that reflect regional taste preferences and consumption habits. Across all regions, supply chain resilience, value-chain integration, and clinical validation remain common strategic levers, but their prioritization varies based on regional market maturity and consumer expectations.

Corporate strategies and competitive dynamics that highlight how innovation, vertical integration, and scientific credibility create durable differentiation

Company-level dynamics are defined by a mix of product innovation, supply-chain integration, and go-to-market flexibility. Leading ingredient providers are investing in advanced fractionation techniques, clinical programs, and collaborative partnerships with academic institutions to strengthen their efficacy claims and create differentiated product specifications. Parallel to this, some firms are pursuing vertical integration-bringing upstream cultivation, extraction, and refinement capabilities in-house-to improve margin control and traceability, while others prefer strategic alliances or toll-manufacturing agreements to maintain agility and limit capital expenditure.

Competitive positioning also hinges on channel strategies and formulation support. Companies that offer application expertise, co-development services, and turnkey formulations increase their attractiveness to brand owners seeking to shorten time-to-market. In addition, supply agreements that incorporate quality assurance protocols, contingency sourcing plans, and sustainability metrics are becoming standard negotiation elements, reflecting buyers' heightened emphasis on continuity and ethical sourcing. Mergers and collaborations are selectively deployed to access proprietary intellectual property, expand geographic reach, or secure botanical supply.

Finally, non-product assets-such as scientific publications, clinical partnerships, and certifications-serve as tangible differentiators in procurement decisions. Companies that consistently invest in these assets not only elevate their credibility with regulatory bodies and customers but also position themselves to capture premium opportunities in applications demanding rigorous substantiation.

Actionable strategic recommendations that guide leaders to balance supply diversification, clinical investment, sustainability, and channel-specific product design

Industry leaders should adopt a portfolio-oriented approach that simultaneously addresses supply risk, evidence generation, and route-to-market optimization. First, diversify botanical sourcing and qualification pipelines to reduce single-source exposure and enable rapid substitution without compromising functional performance. This should be complemented by supplier development programs and multi-year agreements that incentivize quality improvements and capacity investment. Second, prioritize clinical and mechanistic research targeted at the highest-value applications-such as infant nutrition and pharmaceutical adjuncts-to secure defendable claims and premium positioning. Collaborative trials and real-world evidence studies can accelerate acceptance and reduce commercialization friction.

Third, align packaging and format development with channel-specific needs, ensuring that dosage accuracy, shelf stability, and consumer convenience are optimized for both offline retail environments and direct-to-consumer channels. Fourth, embed sustainability and traceability metrics into procurement and marketing frameworks, using certifications, traceable supply chains, and transparent storytelling to meet evolving consumer and regulatory expectations. Fifth, enhance operational resilience by investing in near-shore capacity, flexible manufacturing contracts, and phased inventory strategies that respond to trade disruptions while preserving service levels.

Lastly, cultivate cross-functional capabilities-linking R&D, regulatory affairs, and commercial teams-to ensure that product specifications, evidence packages, and go-to-market narratives are coherent and compelling. Taken together, these actions create a defensible strategic posture that balances growth ambition with disciplined risk management.

A transparent, reproducible research methodology combining primary interviews, literature synthesis, segmentation mapping, and expert validation to underpin recommendations

The research methodology underpinning the analysis combines qualitative and quantitative techniques to ensure robust, actionable insights. Primary research involved structured interviews with industry executives, formulation scientists, procurement leads, and channel partners to capture firsthand perspectives on sourcing constraints, application requirements, and commercialization strategies. Secondary research encompassed review of peer-reviewed journals, regulatory advisories, patent landscapes, and public disclosures to validate technical assertions and identify innovation trajectories. Data triangulation ensured that findings reflected both market practice and the latest scientific understanding of prebiotic function.

Segmentation mapping was conducted by integrating product-type attributes, application constraints, botanical source characteristics, distribution-channel behaviors, and form-specific considerations to create a multidimensional framework that informs strategic choices. Validation rounds with subject-matter experts refined assumptions and clarified uncertainties, while scenario analysis explored potential responses to trade and regulatory developments. Limitations of the study include variability in proprietary formulation practices and the evolving nature of clinical evidence, both of which were mitigated through sensitivity analyses and expert validation.

Overall, the methodology emphasizes transparency, reproducibility, and a pragmatic orientation toward commercial applicability, ensuring that recommendations are grounded in verifiable inputs and informed judgment rather than conjecture.

A concise synthesis emphasizing the imperative to blend scientific proof, supply resilience, and commercial focus to secure long-term competitive advantage

In conclusion, plant-derived prebiotic fiber is at a strategic inflection point where scientific rigor, supply resilience, and commercial creativity determine market outcomes. The industry is shifting from commodity-driven dynamics toward differentiated propositions grounded in clinical substantiation, provenance transparency, and application-specific performance. As trade measures and regional dynamics evolve, companies that proactively diversify supply, prioritize high-value clinical evidence, and tailor formats to channel requirements will retain strategic optionality and capture premium opportunities.

Moreover, integration of sustainability practices and investment in traceability not only addresses regulatory and consumer expectations but also mitigates supply-chain disruptions and strengthens negotiation positions with large buyers. To succeed, organizations must operationalize cross-functional alignment-ensuring R&D, procurement, regulatory, and commercial teams co-design product offerings that are scientifically defensible, manufacturable at scale, and compelling to end users. The path forward requires disciplined execution, continual learning, and the willingness to invest where differentiation yields measurable returns.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Plant-Derived Prebiotic Fiber Market, by Product Type

  • 8.1. Fructo-Oligosaccharides
  • 8.2. Galacto-Oligosaccharides
  • 8.3. Inulin
  • 8.4. Pectin
  • 8.5. Resistant Dextrin

9. Plant-Derived Prebiotic Fiber Market, by Source

  • 9.1. Banana
  • 9.2. Chicory Root
  • 9.3. Garlic
  • 9.4. Jerusalem Artichoke
  • 9.5. Onion

10. Plant-Derived Prebiotic Fiber Market, by Form

  • 10.1. Capsules
  • 10.2. Liquid
  • 10.3. Powder

11. Plant-Derived Prebiotic Fiber Market, by Application

  • 11.1. Animal Feed
  • 11.2. Dietary Supplements
  • 11.3. Food And Beverage
  • 11.4. Pharmaceuticals

12. Plant-Derived Prebiotic Fiber Market, by End User

  • 12.1. Animal Husbandry
  • 12.2. Functional Food
  • 12.3. Infant Formula
  • 12.4. Sports Nutrition

13. Plant-Derived Prebiotic Fiber Market, by Distribution Channel

  • 13.1. Offline
    • 13.1.1. Convenience Stores
    • 13.1.2. Specialty Stores
    • 13.1.3. Supermarket And Hypermarket
  • 13.2. Online
    • 13.2.1. Direct Manufacturer Websites
    • 13.2.2. E-Commerce Platforms

14. Plant-Derived Prebiotic Fiber Market, by Region

  • 14.1. Americas
    • 14.1.1. North America
    • 14.1.2. Latin America
  • 14.2. Europe, Middle East & Africa
    • 14.2.1. Europe
    • 14.2.2. Middle East
    • 14.2.3. Africa
  • 14.3. Asia-Pacific

15. Plant-Derived Prebiotic Fiber Market, by Group

  • 15.1. ASEAN
  • 15.2. GCC
  • 15.3. European Union
  • 15.4. BRICS
  • 15.5. G7
  • 15.6. NATO

16. Plant-Derived Prebiotic Fiber Market, by Country

  • 16.1. United States
  • 16.2. Canada
  • 16.3. Mexico
  • 16.4. Brazil
  • 16.5. United Kingdom
  • 16.6. Germany
  • 16.7. France
  • 16.8. Russia
  • 16.9. Italy
  • 16.10. Spain
  • 16.11. China
  • 16.12. India
  • 16.13. Japan
  • 16.14. Australia
  • 16.15. South Korea

17. United States Plant-Derived Prebiotic Fiber Market

18. China Plant-Derived Prebiotic Fiber Market

19. Competitive Landscape

  • 19.1. Market Concentration Analysis, 2025
    • 19.1.1. Concentration Ratio (CR)
    • 19.1.2. Herfindahl Hirschman Index (HHI)
  • 19.2. Recent Developments & Impact Analysis, 2025
  • 19.3. Product Portfolio Analysis, 2025
  • 19.4. Benchmarking Analysis, 2025
  • 19.5. Baolingbao Biology Co., Ltd.
  • 19.6. Beneo GmbH
  • 19.7. Biofeed Technology, Inc.
  • 19.8. Cargill, Incorporated
  • 19.9. Cosucra Groupe Warcoing S.A.
  • 19.10. DuPont de Nemours, Inc.
  • 19.11. FrieslandCampina Ingredients B.V.
  • 19.12. FUBON Precison Co., Ltd.
  • 19.13. Guangdong VTR Bio-Tech Co., Ltd.
  • 19.14. Ingredion Incorporated
  • 19.15. Kerry Group plc
  • 19.16. Lallemand Inc.
  • 19.17. Matrix Nutrition Inc.
  • 19.18. New Francisco Biotechnology Corporation
  • 19.19. Nissin Sugar Manufacturing Co., Ltd.
  • 19.20. Orffa Additives B.V.
  • 19.21. Quantum Hi-Tech (Beijing) Biotechnology Co., Ltd.
  • 19.22. Sensient Technologies Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 14. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FRUCTO-OLIGOSACCHARIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FRUCTO-OLIGOSACCHARIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FRUCTO-OLIGOSACCHARIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY GALACTO-OLIGOSACCHARIDES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY GALACTO-OLIGOSACCHARIDES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY GALACTO-OLIGOSACCHARIDES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY INULIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY INULIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY INULIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PECTIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PECTIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PECTIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY RESISTANT DEXTRIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY RESISTANT DEXTRIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY RESISTANT DEXTRIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY BANANA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY BANANA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY BANANA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CHICORY ROOT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CHICORY ROOT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CHICORY ROOT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY GARLIC, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY GARLIC, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY GARLIC, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY JERUSALEM ARTICHOKE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY JERUSALEM ARTICHOKE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY JERUSALEM ARTICHOKE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CAPSULES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CAPSULES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CAPSULES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY LIQUID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY LIQUID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY LIQUID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY POWDER, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY POWDER, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY POWDER, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ANIMAL FEED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ANIMAL FEED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ANIMAL FEED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DIETARY SUPPLEMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DIETARY SUPPLEMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DIETARY SUPPLEMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FOOD AND BEVERAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FOOD AND BEVERAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FOOD AND BEVERAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PHARMACEUTICALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PHARMACEUTICALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PHARMACEUTICALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ANIMAL HUSBANDRY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ANIMAL HUSBANDRY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ANIMAL HUSBANDRY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FUNCTIONAL FOOD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FUNCTIONAL FOOD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FUNCTIONAL FOOD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY INFANT FORMULA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY INFANT FORMULA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY INFANT FORMULA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SPORTS NUTRITION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SPORTS NUTRITION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SPORTS NUTRITION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CONVENIENCE STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CONVENIENCE STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY CONVENIENCE STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SPECIALTY STORES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SPECIALTY STORES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SPECIALTY STORES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SUPERMARKET AND HYPERMARKET, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SUPERMARKET AND HYPERMARKET, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SUPERMARKET AND HYPERMARKET, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DIRECT MANUFACTURER WEBSITES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DIRECT MANUFACTURER WEBSITES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DIRECT MANUFACTURER WEBSITES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY E-COMMERCE PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY E-COMMERCE PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY E-COMMERCE PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 102. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 111. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 112. NORTH AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 118. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 119. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 120. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 121. LATIN AMERICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 134. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 135. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 136. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 137. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 138. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 139. EUROPE PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 142. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 143. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 144. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 145. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 146. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 147. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 148. MIDDLE EAST PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 152. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 153. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 154. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 155. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 156. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 157. AFRICA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 158. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 159. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 160. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 161. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 162. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 163. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 164. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 165. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 166. ASIA-PACIFIC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 168. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 169. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 171. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 172. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 173. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 174. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 175. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 176. ASEAN PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 177. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 178. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 180. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 181. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 184. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 185. GCC PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 194. EUROPEAN UNION PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 195. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 196. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 197. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 198. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 199. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 200. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 201. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 202. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 203. BRICS PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 204. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 205. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 206. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 207. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 208. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 209. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 210. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 211. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 212. G7 PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 213. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 216. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 217. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 218. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 219. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 220. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 221. NATO PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 223. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 224. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 225. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 226. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 227. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 229. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 230. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 231. UNITED STATES PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)
  • TABLE 232. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 233. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 234. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY SOURCE, 2018-2032 (USD MILLION)
  • TABLE 235. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY FORM, 2018-2032 (USD MILLION)
  • TABLE 236. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 237. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 239. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY OFFLINE, 2018-2032 (USD MILLION)
  • TABLE 240. CHINA PLANT-DERIVED PREBIOTIC FIBER MARKET SIZE, BY ONLINE, 2018-2032 (USD MILLION)